← Eichor
Study identifier: NCT07585799 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Permanent Conduction System Pacing Versus Atrioventricular Management for Patients With Wide QRS and Patent AV Conduction

Condition: Bradycardia  ·  Sponsor: Óscar Cano Pérez

PhaseNA
Planned participants120
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Intraventricular conduction delay alone or in combination with AV conduction delay is associated with a dyssynchronous activation of the ventricles and may result in LV function impairment. Conduction system pacing can restore physiologic ventricular activation in the presence of intraventricular and atrioventricular conduction delays. Patients with intraventricular conduction delay alone or in combination with AV conduction delay who have a permanent pacemaker indication due to intermittent bradycardia and have predominantly intact AV conduction may benefit from continuous CSP.

This description comes directly from the study's public registry record.

Talk to the study team

Óscar Cano, MD, PhD  ·  +34 961244000  ·  cano_osc@gva.es

Bernabé López, MD  ·  +34 961244000

Always discuss trial participation with your own doctor first.

Locations (3)

Hospital Universitario Virgen de las NievesGranada, Andalusia, SpainRecruiting
Hospital Clínico Universitario Lozano BlesaZaragoza, Aragon, SpainRecruiting
Hospital Universitari i Politècnic La FeValencia, Valencia, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07585799